These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 1355664)

  • 1. Comparison of ketanserin and celiprolol on regression of left ventricular hypertrophy in older hypertensive patients.
    Vyssoulis GP; Karpanou EA; Pitsavos CE; Kourtis TK; Paleologos AA; Toutouzas PK
    Cardiovasc Drugs Ther; 1992 Aug; 6(4):419-24. PubMed ID: 1355664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left ventricular hypertrophy regression and function changes with ketanserin in elderly hypertensives.
    Vyssoulis GP; Karpanou EA; Pitsavos CE; Paleologos AA; Kourtis TK; Toutouzas PK
    Cardiovasc Drugs Ther; 1990 Jan; 4 Suppl 1():81-4. PubMed ID: 2149517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regression of left ventricular hypertrophy and systolic function in hypertensive patients during long-term treatment with ketanserin.
    Coto V; Cocozza M; Oliviero U; Lucariello A; Picano T; Castaldo B; Iovino V; Cacciatore L
    Cardiovasc Drugs Ther; 1990 Jan; 4 Suppl 1():77-80. PubMed ID: 2149516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term reduction of peripheral resistance with celiprolol and effects on left ventricular mass.
    Trimarco B; Lembo G; DeLuca N; Ricciardelli B; Rosiello G; Volpe M; Orofino G; Condorelli M
    J Int Med Res; 1988; 16 Suppl 1():62A-72A. PubMed ID: 2906018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular mass and ventricular function after celiprolol in Wistar-Kyoto and spontaneously hypertensive rats.
    Horinaka S; Frohlich ED
    Cardiovasc Res; 1992 Apr; 26(4):396-400. PubMed ID: 1353414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of diastolic function after reversal of left ventricular hypertrophy induced by long-term antihypertensive treatment with tertatolol.
    Trimarco B; De Luca N; Rosiello G; Ricciardelli B; Betocchi S; Filardi PP; Raponi M; Condorelli M
    Am J Cardiol; 1989 Oct; 64(12):745-51. PubMed ID: 2572165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of left ventricular hypertrophy in hypertensive patients after treatment with celiprolol.
    Herrmann JM; Bischof F; Von Heymann F; Mayer EO; Freischuetz G; Burghagen H
    Am J Cardiol; 1988 Feb; 61(5):55C-56C. PubMed ID: 2963527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive therapy with celiprolol: a new cardioselective beta blocker.
    Norris RJ
    Am J Cardiol; 1988 Feb; 61(5):14C-22C. PubMed ID: 2893531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term effects of celiprolol on blood pressure and left ventricular performance in hypertensive cardiomyopathy.
    Rodríguez Rodrigo FJ; Ruiz I; Lorenzo JG; Alay D; Terol I; Cuenca P; Plaza L
    J Cardiovasc Pharmacol; 1992; 20(5):683-7. PubMed ID: 1280728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of long-term antihypertensive treatment with tertatolol on diastolic function in hypertensive patients with and without left ventricular hypertrophy.
    Trimarco B; DeLuca N; Rosiello G; Ricciardelli B; Marchegiano R; Condorelli G; Raponi M; Condorelli M
    Am J Hypertens; 1989 Nov; 2(11 Pt 2):278S-283S. PubMed ID: 2573376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of ketanserin on left ventricular hypertrophy in hypertensive patients.
    Cobo C; Alcocer L; Chávez A
    Cardiovasc Drugs Ther; 1990 Jan; 4 Suppl 1():73-6. PubMed ID: 2149515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of celiprolol on cardiac hypertrophy in hypertension.
    Haneda T; Ogawa Y; Kato J; Matsuhashi H; Morimoto H; Honda H; Takenaka T; Tanazawa S; Kataoka R; Kikuchi K
    Hypertens Res; 2000 Sep; 23(5):467-74. PubMed ID: 11016801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different hemodynamic effects of celipropol and atenolol in patients with mild to moderate hypertension.
    Saner H; Seiler A; Mahler F
    Arzneimittelforschung; 1995 Jul; 45(7):790-5. PubMed ID: 8573224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rest and exercise haemodynamic evaluation of a new cardio-selective beta-adrenoceptor blocker celiprolol alone and in combination with nitroglycerine in ischaemic heart disease.
    Silke B; Verma SP; Frais MA; Reynolds G; Taylor SH
    Br J Clin Pharmacol; 1986 Dec; 22(6):697-706. PubMed ID: 2882772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic effects of celiprolol in essential hypertension.
    Frohlich ED; Ketelhut R; Kaesser UR; Losem CJ; Messerli FH
    Am J Cardiol; 1991 Aug; 68(5):509-14. PubMed ID: 1678580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the antihypertensive effects of celiprolol and enalapril.
    Ghiringhelli S; Cozzi E; Tsialtas D
    J Int Med Res; 1988; 16 Suppl 1():73A-79A. PubMed ID: 2906019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of celiprolol, a new cardioselective beta 1-adrenergic blocker with vasodilating properties, in the treatment of mild to moderate hypertension in the elderly.
    Lamon KD
    Cardiovasc Drugs Ther; 1991 Jan; 4 Suppl 6():1291-5. PubMed ID: 1672605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute haemodynamic profile of celiprolol in patients with coronary heart disease and hypertension: a double-blind comparison with metoprolol.
    Heublein B; Modersohn D; Franz N; Panzner B
    Eur Heart J; 1991 May; 12(5):617-23. PubMed ID: 1678705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of celiprolol on systemic and forearm circulation in hypertensive patients: a double-blind cross-over study versus metoprolol.
    Trimarco B; Lembo G; De Luca N; Ricciardelli B; Rosiello G; Volpe M; Orofino G; Condorelli M
    J Clin Pharmacol; 1987 Aug; 27(8):593-600. PubMed ID: 2888795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of beta-adrenergic blockade on exercise performance in patients with chronic atrial fibrillation.
    Atwood JE; Sullivan M; Forbes S; Myers J; Pewen W; Olson HG; Froelicher VF
    J Am Coll Cardiol; 1987 Aug; 10(2):314-20. PubMed ID: 2885354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.